DermaSensor is an FDA-cleared AI device for primary care physicians that scans suspicious skin lesions and flags melanoma, basal cell carcinoma and squamous cell carcinoma risk in seconds. Its key features include a non-invasive spectroscopy scan that needs no biopsy, a locked AI algorithm that returns a “Monitor” or “Investigate Further” result with a 1-10 score, cloud sync with remote monitoring, and reimbursement support through The Reimbursement Group. It’s an adjunct tool that helps physicians decide when to refer to a dermatologist, not a diagnostic or screening tool. It’s designed for family and internal medicine practices, from independent clinics to large health systems.
Leave a Reply